January 6, 2016 — A new study has confirmed that women who take the antidepressant Paxil in early pregnancy are more likely to have a baby with a birth defect.

The study, published in the British Journal of Clinical Pharmacology, is a systematic review of 23 studies published from 1966 to November 2015.

Compared to non-users, women who used Prozac in the first trimester were 23% more likely to have a baby with a birth defect. The risk of heart defects was also significantly increased — including a 2.4X increased risk of atrial septal defect (“hole in the heart”) and a 2.3X increased risk of pulmonary atresia.

The study confirms results from another study published last year in the British Medical Journal, which linked first-trimester use of Paxil and the following defects:

  • Anencephaly — 3.2X increased risk
  • Atrial septal defects — 1.8X increased risk
  • Right ventricular outflow defect — 2.4X increased risk
  • Gastroschisis — 2.5X increased risk
  • Omphalocele — 3.5X increased risk

Babies exposed to Prozac in early pregnancy also had higher rates of certain birth defects, including a heart defect and a skull defect known as craniosynostosis. However, researchers cautioned that the absolute risk was low — for example, taking Paxil in early pregnancy increased the estimated risk of anencephaly from 2 babies per 10,000 to 7 babies per 10,000.

Meet Your Attorney

Collen A. Clark

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

“Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

To contact Collen, please fill out the contact form below:

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 879-3040.
  • This field is for validation purposes and should be left unchanged.